Meeting of the Community Preventive Services Task Force (CPSTF), 5439-5440 [2020-01732]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)- SIP20–009, StateBased Health, Budget Impact and CostEffectiveness of Improved Coverage and
Uptake of Smoking Cessation.
Date: April 28, 2020.
Time: 11:00 a.m.—6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer, CDC,
4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341; Telephone: (770) 488–6511;
kva5@cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–01623 Filed 1–29–20; 8:45 am]
in Puerto Rico; RFA–CK–20–002,
Detection and Characterization of
Emerging Vector-Borne Zoonotic
Pathogens in Indonesia; and RFA–CK–
20–003, Modeling Infectious Diseases in
Healthcare Research Projects to Improve
Prevention Research and Healthcare
Delivery (MInD Healthcare).
Date: March 31, 2020–April 1, 2020
Time: 10:00 a.m.–5:00 p.m., EDT
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–01619 Filed 1–29–20; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)RFA–CK–20–001, Enhanced
Surveillance and Control of Arboviruses
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Centers for Disease Control and
Prevention
Meeting of the Community Preventive
Services Task Force (CPSTF)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The CDC within the HHS
announces the next meeting of the
CPSTF on February 12, 2020.
DATES: The meeting will be held on
Wednesday, February 12, 2020, from
8:30 a.m. to 5:00 p.m. EST.
ADDRESSES: The CPSTF meeting will be
held via web conference. Information
regarding meeting logistics will be
available on the Community Guide
website (www.thecommunityguide.org)
closer to the date of the meeting.
FOR FURTHER INFORMATION CONTACT:
Onslow Smith, Community Guide
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
5439
E–69, Atlanta, GA 30329, phone: (404)
498–6778, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Meeting Accessibility: This CPSTF
meeting will be a one-day session held
virtually. The morning session will
consist of internal CPSTF business
related to its 2020 process for
establishing its priority topics for 2021–
2025. The afternoon session will consist
of deliberation on systematic reviews of
literature. The afternoon session is open
to the public from 1:00 to 5:00 p.m. EST.
All participants who would like to
attend the afternoon session must
register by 5:00 p.m. EST on Friday,
February 7, 2020. Participants will
receive registration confirmation with
web conference meeting instructions
within two business days.
To register for the afternoon session,
individuals should send an email to
CPSTF@cdc.gov and include the
following information: Name, title,
organization name, organization
address, phone, email. CDC will email
web conference information from the
CPSTF@cdc.gov mailbox. Additional
logistical information regarding this
virtual meeting will be available on the
Community Guide website
(www.thecommunityguide.org) closer to
the date of the meeting.
Public Comment: Individuals who
would like to make public comments
must indicate their desire to do so with
their registration by providing their
name, organizational affiliation, and the
topic to be addressed (if known). The
requestor will receive instructions for
the public comment process for this
virtual meeting after the request is
received. A public comment period
follows the CPSTF’s discussion of each
systematic review and is limited to three
minutes per person. Public comments
will become part of the meeting
summary.
Background on the CPSTF: The
CPSTF is an independent, nonfederal
panel whose members are appointed by
the CDC Director. CPSTF members
represent a broad range of research,
practice, and policy expertise in
prevention, wellness, health promotion,
and public health. The CPSTF was
convened in 1996 by the HHS to
identify community preventive
programs, services, and policies that
increase healthy longevity, save lives
and dollars, and improve Americans’
quality of life. CDC is mandated to
provide ongoing administrative,
research, and technical support for the
operations of the CPSTF. During its
meetings, the CPSTF considers the
findings of systematic reviews of
literature on existing research and
E:\FR\FM\30JAN1.SGM
30JAN1
5440
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
practice-based evidence and issues
recommendations. CPSTF
recommendations are not mandates for
compliance or resource allocation.
Instead, they provide information about
evidence-based options that decision
makers and stakeholders can consider
when they are determining what best
meets the specific needs, preferences,
available resources, and constraints of
their jurisdictions and constituents. The
CPSTF’s recommendations, along with
the systematic reviews of the evidence
on which they are based, are compiled
in the The Community Guide.
Matters proposed for discussion: The
CPSTF will discuss the 2020 process for
establishing its priority topics for 2021–
2025 during a closed session the first
half of the day. During the afternoon
session which is open to the public, the
CPSTF will deliberate on systematic
reviews of literature related to the
following: HIV Prevention: Clinical
Decision Support Systems to Increase
HIV Screening; Cardiovascular Disease
Prevention and Control: Economics of
Pharmacy-Based Interventions to
Increase Medication Adherence; and
one or more proposals for new reviews
in the areas of mental health, sleep
health, tobacco prevention and control.
The agenda is subject to change without
prior notice; however, agenda updates
will be posted on the the Community
Guide website
(www.thecommunityguide.org).
Dated: January 27, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CK–20–004, Prevention Epicenters
Program: Protecting Patients from
Infections, Antibiotics Resistance and
Other Adverse Events.
Date: May 21, 2020.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
Jkt 250001
[FR Doc. 2020–01621 Filed 1–29–20; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
16:56 Jan 29, 2020
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–01620 Filed 1–29–20; 8:45 am]
[FR Doc. 2020–01732 Filed 1–29–20; 8:45 am]
VerDate Sep<11>2014
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–20–005, Rapid-Cycle Survey
Collaborative for Patient and Provider
Input on Immunization Issues.
Date: April 21, 2020.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), ICD–10 Coordination and
Maintenance (C&M) Committee
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention, National Center
for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, announces the
following meeting of the ICD–10
Coordination and Maintenance (C&M)
Committee meeting. This meeting is
open to the public, limited only by the
space available. The meeting room
accommodates approximately 240
SUMMARY:
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Pages 5439-5440]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01732]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Community Preventive Services Task Force (CPSTF)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The CDC within the HHS announces the next meeting of the CPSTF
on February 12, 2020.
DATES: The meeting will be held on Wednesday, February 12, 2020, from
8:30 a.m. to 5:00 p.m. EST.
ADDRESSES: The CPSTF meeting will be held via web conference.
Information regarding meeting logistics will be available on the
Community Guide website (www.thecommunityguide.org) closer to the date
of the meeting.
FOR FURTHER INFORMATION CONTACT: Onslow Smith, Community Guide Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-E-
69, Atlanta, GA 30329, phone: (404) 498-6778, email: [email protected].
SUPPLEMENTARY INFORMATION:
Meeting Accessibility: This CPSTF meeting will be a one-day session
held virtually. The morning session will consist of internal CPSTF
business related to its 2020 process for establishing its priority
topics for 2021-2025. The afternoon session will consist of
deliberation on systematic reviews of literature. The afternoon session
is open to the public from 1:00 to 5:00 p.m. EST. All participants who
would like to attend the afternoon session must register by 5:00 p.m.
EST on Friday, February 7, 2020. Participants will receive registration
confirmation with web conference meeting instructions within two
business days.
To register for the afternoon session, individuals should send an
email to [email protected] and include the following information: Name,
title, organization name, organization address, phone, email. CDC will
email web conference information from the [email protected] mailbox.
Additional logistical information regarding this virtual meeting will
be available on the Community Guide website (www.thecommunityguide.org)
closer to the date of the meeting.
Public Comment: Individuals who would like to make public comments
must indicate their desire to do so with their registration by
providing their name, organizational affiliation, and the topic to be
addressed (if known). The requestor will receive instructions for the
public comment process for this virtual meeting after the request is
received. A public comment period follows the CPSTF's discussion of
each systematic review and is limited to three minutes per person.
Public comments will become part of the meeting summary.
Background on the CPSTF: The CPSTF is an independent, nonfederal
panel whose members are appointed by the CDC Director. CPSTF members
represent a broad range of research, practice, and policy expertise in
prevention, wellness, health promotion, and public health. The CPSTF
was convened in 1996 by the HHS to identify community preventive
programs, services, and policies that increase healthy longevity, save
lives and dollars, and improve Americans' quality of life. CDC is
mandated to provide ongoing administrative, research, and technical
support for the operations of the CPSTF. During its meetings, the CPSTF
considers the findings of systematic reviews of literature on existing
research and
[[Page 5440]]
practice-based evidence and issues recommendations. CPSTF
recommendations are not mandates for compliance or resource allocation.
Instead, they provide information about evidence-based options that
decision makers and stakeholders can consider when they are determining
what best meets the specific needs, preferences, available resources,
and constraints of their jurisdictions and constituents. The CPSTF's
recommendations, along with the systematic reviews of the evidence on
which they are based, are compiled in the The Community Guide.
Matters proposed for discussion: The CPSTF will discuss the 2020
process for establishing its priority topics for 2021-2025 during a
closed session the first half of the day. During the afternoon session
which is open to the public, the CPSTF will deliberate on systematic
reviews of literature related to the following: HIV Prevention:
Clinical Decision Support Systems to Increase HIV Screening;
Cardiovascular Disease Prevention and Control: Economics of Pharmacy-
Based Interventions to Increase Medication Adherence; and one or more
proposals for new reviews in the areas of mental health, sleep health,
tobacco prevention and control. The agenda is subject to change without
prior notice; however, agenda updates will be posted on the the
Community Guide website (www.thecommunityguide.org).
Dated: January 27, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2020-01732 Filed 1-29-20; 8:45 am]
BILLING CODE 4163-18-P
